A mouse model of human ANCA glomerulonephritis will be studied to advance the understanding of the pathogenic processes that cause glomerular injury and the immunogenic events that lead to the autoimmune response. The model involves transfer of anti-MPO antibody or anti-MPO lymphocytes (derived from MPO-/- mice immunized with mouse MPO) into recipient mice with normal MPO production.
Specific Aim 1 will test the hypothesis that neutrophils are the primary effector cells of anti-MPO glomerulonephritis, and disease induction is influenced by factors that enhance or diminish neutrophil activity.
Specific Aim 2 will test the hypothesis that anti-MPO glomerulonephritis can be induced by specific sense and anti-sense peptides, and involves escape from regulatory mechanisms. The role of neutrophils will be evaluated by assessing the effects of depletion of neutrophils, enhancement of neutrophil function, blockade of neutrophil function, and use of knock out mice lacking important neutrophil effector functions. The relative pathogenic importance of anti-MPO T cells versus anti-MPO IgG will be evaluated by comparison of disease induction by transfer of varying proportions of anti-MPO T cell and B cells. The relative immunogenicity and pathogenicity of different MPO epitopes will be investigated by using different recombinant sense and complementary murine MPO peptides to prepare anti-MPO antibodies for the model. The role for regulatory lymphocytes in the down regulation of anti-MPO autoimmunity will be investigated by transferring different subsets of lymphocytes from immune competent mice that have suppressed anti-mouse MPO activity into immune deficient RAG2-/- mice that have adopted an anti-MPO immune response to asses the suppression of the anti-MPO autoimmune response. The proposed research will refine our understanding of the pathogenesis of ANCA glomerulonephritis and should point to improved therapeutic strategies for this aggressive disease, which is very important because current treatment of ANCA glomerulonephritis is not fully effective and is toxic.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK058335-09
Application #
7667831
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
9
Fiscal Year
2008
Total Cost
$250,931
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
McCall, A Scott; Bhave, Gautam; Pedchenko, Vadim et al. (2018) Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes. J Am Soc Nephrol 29:2619-2625
Alba, Marco A; Jennette, J Charles; Falk, Ronald J (2018) Pathogenesis of ANCA-Associated Pulmonary Vasculitis. Semin Respir Crit Care Med 39:413-424
Weiner, Maria; Bjørneklett, Rune; Hrušková, Zdenka et al. (2018) Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Nephrol Dial Transplant :
van Daalen, Emma E; Jennette, J Charles; McAdoo, Stephen P et al. (2018) Predicting Outcome in Patients with Anti-GBM Glomerulonephritis. Clin J Am Soc Nephrol 13:63-72
Thorpe, Carolyn T; Thorpe, Joshua M; Jiang, Tao et al. (2018) Healthcare utilization and expenditures for United States Medicare beneficiaries with systemic vasculitis. Semin Arthritis Rheum 47:507-519
Alba, Marco A; Flores-Suárez, Luis Felipe; Henderson, Ashley G et al. (2017) Interstital lung disease in ANCA vasculitis. Autoimmun Rev 16:722-729
Cortazar, Frank B; Pendergraft 3rd, William F; Wenger, Julia et al. (2017) Effect of Continuous B Cell Depletion With Rituximab on Pathogenic Autoantibodies and Total IgG Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol 69:1045-1053
Payan Schober, Fernanda; Jobson, Meghan A; Poulton, Caroline J et al. (2017) Clinical Features and Outcomes of a Racially Diverse Population with Fibrillary Glomerulonephritis. Am J Nephrol 45:248-256
Jones, Britta E; Yang, Jiajin; Muthigi, Akhil et al. (2017) Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis. J Am Soc Nephrol 28:1175-1187
Merkel, Peter A; Xie, Gang; Monach, Paul A et al. (2017) Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis. Arthritis Rheumatol 69:1054-1066

Showing the most recent 10 out of 86 publications